Astex Pharmaceuticals, Inc. (ASTX) Management Discusses Q2 2013 Results (Webcast)

Aug. 1.13 | About: Astex Pharmaceuticals, (ASTX)

Astex Pharmaceuticals (ASTX): Q2 EPS of -$0.04 beats by $0.02. Revenue of $16.6M beats by $1.1M. (PR)

The following audio is from an earnings conference call that began on August 1, 2013, at 8:00 AM ET. The audio is live-streaming while the call is active, and can be replayed upon its completion.